Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Genetic testing for EGFR mutations is crucial in similar cases.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Researchers created a mouse cell line to study hair growth and test hair growth drugs.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.